A retrospective study of Covid-19 vaccines for symptomatic and asymptomatic SARS-CoV-2 infections in different population subgroups
Latest Information Update: 04 Jan 2023
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 04 Jan 2023 New trial record
- 20 Dec 2022 Results published in the Vaccine